【レポートの概要（一部）】
1. Report Overview
1.1 World IBD Drugs Market: Overview of Findings
1.2 Why You Should Read This Report
1.3 How That Study Delivers Value
1.4 Main Questions Covered in That Analysis
1.5 Who is the Investigation For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQ)
1.8 Some Associated Titles
1.9 About Visiongain
2. Introduction to the Inflammatory Bowel Disease Market
2.1 What is Inflammatory Bowel Disease (IBD)?
2.2 Classification of IBD
2.3 Symptoms and Diagnosis of IBD
2.4 Multifactorial Causes of IBD
2.5 How Common is IBD?
2.6 What Are the Treatment Options for IBD?
2.6.1 Aminosalicylates – The Most Common Therapy
2.6.2 Antibiotics – Will There Be Any Supporting Evidence Soon?
2.6.3 Corticosteroids – Uptake from Uceris?
2.6.4 Immunomodulators – Slow to Act?
2.6.5 Monoclonal Antibodies – Not Cost-effective?
2.7 Treatment Goals for IBD – Treat-to-Target Approach?
2.8 Treatment Algorithm – is Top-Down Approach the Future Direction?
3. The World Inflammatory Bowel Disease Market, 2014-2025
3.1 The Inflammatory Bowel Disease Market in 2013 and 2014
3.2 Forecast 2014-2025: Changes Expected?
3.3 Biologic Therapies Forecast 2014-2025 – The Future of Pharma
3.4 Aminosalicylates Forecast 2014-2025: The Work Horse of IBD Market
3.5 Antibiotics Forecast 2014-2025: Scientific Research Important
3.6 Corticosteroids Forecast 2014-2025: Will Uceris Save the Day?
3.7 Immunomodulators Forecast 2014-2025 – Will It Remain Insignificant?
4. Market Prospects for Leading IBD Drugs, 2014-2025
4.1 Humira (AbbVie) – Will It Stand the Wave of Biosimilars?
4.1.1 Humira: Forecast and Analysis, 2014-2025
4.2 Remicade (Janssen Biotech) – Rise and Fall with Humira?
4.2.1 Remicade: Forecast and Analysis, 2014-2025
4.3 Asacol (Actavis) – Will It Regain Its Revenue?
4.3.1 Asacol: Forecast and Analysis, 2014-2025
4.4 Pentasa (Shire) – When Will a Generic Substitute Arrive?
4.4.1 Pentasa: Forecast and Analysis, 2014-2025
4.5 Lialda (Shire) – Will Improved Compliance Increase Revenue?
4.5.1 Lialda: Forecast and Analysis, 2014-2025
4.6 Tysabri (Perrigo) – How Dependable its Prospects?
4.6.1 Tysabri: Forecast and Analysis, 2014-2025
4.7 Xifaxan (Salix Pharmaceuticals) – Growing Stronger?
4.7.1 Xifaxan: Forecast and Analysis, 2014-2025
4.8 Cimzia (UCB) – How Will it Fare Against Biosimilars?
4.8.1 Cimzia: Forecast and Analysis, 2014-2025
4.9 Entocort (AstraZeneca) – A Slow and Steady Decline?
4.9.1 Entocort: Forecast and Analysis, 2014-2025
4.10 Neoral (Novartis) – Immunosuppressant
4.10.1 Neoral: Forecast and Analysis, 2014-2025
4.11 Medrol (Pfizer Inc.) – Another Leading Steroid
4.11.1 Medrol: Forecast and Analysis, 2014-2025
4.12 Canasa (Actavis) – A Slow Decline?
4.12.1 Canasa/Salofalk: Forecast and Analysis, 2014-2025
4.13 Apriso (Salix Pharmaceuticals) – Challenger to Asacol?
4.13.1 Apriso: Forecast and Analysis, 2014-2025
4.14 Azulfidine (Pfizer) – Established Product
4.14.1 Azulfidine: Forecast and Analysis, 2014-2025
4.15 Entyvio (Takeda Pharmaceuticals) – a Future Star Product?
4.15.1 Entyvio: Forecast and Analysis, 2014-2025
4.16 Simponi (Janssen Biotech) – Another Rising Star for the Market?
4.16.1 Simponi: Forecast and Analysis, 2014-2025
4.17 Uceris (Salix) – Corticosteroid for Maintenance Therapy?
4.17.1 Uceris: Forecast and Analysis, 2014-2025
5. Leading National Markets: Sales Outlooks, 2014-2025
5.1 IBD Drugs – Leading National Markets 2013
5.2 The US IBD Drug Market, 2014-2025 – The World Leader
5.3 The Japanese IBD Drug Market, 2014-2025 – Growing Significantly?
5.4 The EU-5 IBD Drug Market, 2014-2025 – Still Growing Together
5.4.1 The German IBD Drug Market, 2014-2025
5.4.2 The French IBD Drug Market, 2014-2025
5.4.3 The UK IBD Drug Market, 2014-2025
5.4.4 The Spanish IBD Drug Market, 2014-2025
5.4.5 The Italian IBD Drug Market, 2014-2025
5.5 IBD Drug Markets in BRIC Countries – How Fast Will They Grow?
5.5.1 The Brazilian IBD Drug Market, 2014-2025
5.5.2 The Russian IBD Drug Market, 2014-2025
5.5.3 The Indian Drug Market, 2014-2025
5.5.4 The Chinese IBD Drug Market, 2014-2025
6. The R&D Pipeline for Inflammatory Bowel Disease, 2014
6.1 Interleukin (IL) Inhibitors – One of the Main Areas of Innovation
6.1.1 CyCol (Sigmoid Pharma)
6.1.2 PF-04236921 (Pfizer)
6.1.3 QAX 576 (Novartis)
6.1.4 TNF Kinoid (Neovacs)
6.1.5 Vidofludimus (4SC) – Suspended
6.1.6 Stelara (Ustekinumab, CNTO 1275, Janssen Biotech)
6.2 Cell-Adhesion Molecule (CAM) Inhibitors – A Promising Avenue
6.2.1 AJG 511 (Ajinomoto Pharmaceutical Co.)
6.2.2 AJM 300 (Ajinomoto Pharmaceuticals)
6.2.3 MEDI 7183/AMG 181 (AstraZeneca & Amgen)
6.2.4 Etrolizumab (Roche)
6.2.5 PF-00547659 (Pfizer)
6.2.6 Alicaforsen (ISIS 2302, Atlantic Healthcare)
6.2.7 MEDI-2070/AMG 139 (AstraZeneca & Amgen)
6.2.8 Entyvio (Vedolizumab, Takeda)
6.3 TNF Inhibitors – a Specific Target
6.3.1 AVX-470 (Avaxia Biologics)
6.3.2 Ozoralizumab (ALX-0061, Ablynx)
6.4 Stem Cell Therapies – Basis for a Cure?
6.4.1 Ovasave (TxCell)
6.4.2 MultiStem (Athersys and Pfizer)
6.4.3 Prochymal (Remestemcel-L, Osiris Therapeutics)
6.4.4 Cx601 (TiGenix
6.5 JAK Inhibitors – New Target Pathway
6.5.1 JNJ-54781532 (Janssen)
6.5.2 Xeljanz, (Tofacitinib, CP-690550, Pfizer)
6.6 Toll-like Receptor Agonists
6.6.1 BL-7040 (BioLineRX)
6.6.2 Kappaproct (InDex Pharmaceuticals)
6.7 Other Classes of Agent
6.7.1 Trichuris suis ova (CNDO-201, Coronado Biosciences)
6.7.2 GLPG0974 (Galapagos)
6.7.3 RPC1063 (Receptos)
6.7.4 SGX203 (Soligenix)
6.7.5 Mongersen (GED-0301, Celgene)
6.7.6 Tetomilast (OPC-6535, Otsuka)
6.7.7 Laquinimod (Active Biotech)
6.7.8 RHB-104 (RedHill Biopharma)
6.7.9 TRK 170 (Toray Industries)
6.8 Biosimilars Candidates – Promising Copies of Leading Biologics?
6.8.1 Possibility of Adalimumab Biosimilars
6.8.2 Possibility of Infliximab Biosimilars
7. Drivers and Restraints in the Inflammatory Bowel Disease Drug Industry and Market, 2015
7.1 SWOT and STEP Analysis of the IBD Market
7.2 What Factors Will Stimulate the IBD Market?
7.2.1 Increasing Disease Incidence
7.2.2 Better Diagnosis – Early Referrals
7.2.3 Delivery Systems
7.2.4 Biological Drugs
7.2.5 Socioeconomic Costs of IBD
7.3 What Factors Will Restrain the Market?
7.3.1 Lack of Understanding of Disease Aetiology
7.3.2 Compliance
7.3.3 Limits of Biologics
7.3.4 The Possible Development of Alternative Treatments
7.3.5 Surgery – Treatment for Recalcitrant IBD
7.3.6 Health Care Cost Containment
8. Leading Companies in the IBD Market, 2014
8.1 The Largest Companies by Revenue
8.1.1 AbbVie – Current Leader and Continually Expanding
8.1.2 Janssen Biotech – Contender for Future Leader of that Market
8.1.3 Actavis – New Comer in the Top Four
8.1.4 Shire Pharmaceuticals – Products and R&D
9. Research Interviews
9.1 Dr Karine Kleinhaus, Divisional Vice President, North America, Pluristem Therapeutics Inc.
9.1.1 On Pluristem Therapeutics Inc.
9.1.2 On PLX Cells
9.1.3 MoA of PLX Cells and What They are Indicated For
9.1.4 Clinical Trial for IBD Indication
9.1.5 Prospects of PLX Cells as a Treatment Option for IBD
9.1.6 On NIH’s Initiation of the Human Placental Project
9.1.7 Cell Therapy and its Place in Biopharma Development
9.1.8 Bridging Clinical Trial and Clinical Outcome
9.1.9 On Pluristem’s Partnerships
9.2 Dr Qamar ul Arfin, Gastroenterologist, Aga Khan University Hospital, Karachi, Pakistan
9.2.1 On Antibiotics in Treating IBD
9.2.2 On the Emergence of Biologic Therapies
9.2.3 On IBD in the Pakistani Context
9.2.4 On Preventative Measures that Can Be Taken
10. Conclusions of the Study
10.1 IBD Market to Expand from 2014 to 2025
10.2 Aminosalicylates and Other Non-Biologic Treatments
10.3 Biological Treatments
10.4 Improvements Needed in IBD Therapy
10.5 Future IBD Treatments: R&D Efforts Look Promising
10.6 The IBD Sector: Looking to the Future with Confidence
【レポート販売概要】
■ タイトル：世界の炎症性腸疾患(IBD)治療薬市場■ 英文：Inflammatory Bowel Diseases (IBD): World Drug Industry and Market 2015-2025
■ 発行日：2014年11月
■ 調査会社：visiongain
■ 商品コード：VGAIN4120208
■ 調査対象地域：グローバル
- バイオ・ポリエチレンテレフタレートの世界市場The report covers the global bio-polyethylene terephthalate market that is segmented on the basis of application and geography. The global bio-polyethylene terephthalate market was valued at $457.9 million in 2014, and is projected to reach $1,317.5 million by 2019, at a CAGR of 23.5% from 2014 to 2019. The global bio-polyethylene terephthalate market has been analyzed based on the current proceed …
- 保護用作業服の世界市場About Protective WorkwearOne of the prominent categories of the personal protective clothing is protective workwear or protective clothing. This is protective or safety apparel that is worn by workers for protection against various thermal, chemical, mechanical, and biological hazards. Such clothing is usually made of aramid and blends, polyolefins and blends, polyamides, polybenzimidazole (PBI), …
- 世界の点眼薬市場：データ、分析、予測（～2024）Which ophthalmic drugs lead the market in 2013? Will the same drugs be as successful in 2018? How will this landscape change across the next 10 years? Which trial drugs are likely to make an impact? Only one report will tell you the answers. Simply by ordering and reading GMR Data’s new ‘Ophthalmic Drugs; Data, Analysis and Forecasts to 2024’ report, you can stay ahead of your competition. It real …
- 世界のエンジニアリングプラスチック市場：PA、ABS、フルオロポリマー、PCAbout Engineering Plastics Engineering plastics are a class of plastic materials that have superior properties, such as mechanical strength and resistance to heat and chemicals, compared to conventional plastics. Such materials are used in a wide range of applications in industries such as Automotive and Transportation, Electrical and Electronics, Packaging, Appliances, and Consumer Goods. They ar …
- Cebranopadol（神経因性疼痛）：医薬品市場予測及び分析（～2022）Cebranopadol (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Althou …
- 機械安全防護ソリューションの世界市場2019-2023About this market Vendors in the global machine safeguarding solutions market have traditionally relied on conventional solutions such as physical barriers, emergency stop switches, and two-hand control switches. Vendors in the market are increasingly offering products that increase the effectiveness of machine safeguarding solutions. These solutions automate the process of stopping machines and e …
- OAO AK Transneft：石油・ガスバリューチェーン分析レポート2013OAO AK Transneft Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "OAO AK Transneft" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “OAO AK Transneft”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the com …
- ハイパーコンバージドインフラストラクチャの世界市場2019-2023About this market The simplicity offered by hyper-converged infrastructure in management is one of the key factors expected to trigger the market’s growth in the forthcoming years. HCI systems provide simple software on the servers already present in their on-premises data centers. In addition, these systems converge the storage and computation functionalities into a single highly virtualized solu …
- 塩素(CL)の世界市場予測Chlorine 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about chlorine market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part, the re …
- 世界の石炭産業As much as governments around the world would like to reduce dependency on this fossil fuel, it seems highly likely that the global consumption of coal is not going to go down anytime soon. Coal remains one of the most popular sources of energy around the world even today, in spite of the environmental concerns revolving the burning and mining of coal. With coal being used primarily as a solid fue …
- 視神経炎(Optic Neuritis)：世界の治験レビュー（2015年上半期版）Optic Neuritis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Optic Neuritis Global Clinical Trials Review, H1, 2015" provides data on the Optic Neuritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Optic Neuritis. It includes an overview of the trial numbers and their recruitment status as per …
- 植物生育箱（グロースチャンバー）の世界市場2018-2022About Plant Growth Chamber Plant growth chambers are a special type of environmental test chambers that are designed to perform plant growth experiments inside the laboratory to maximize plant growth. They facilitate the control of temperature, light, and humidity, to create a favorable environment in the chambers required for research and testing of a seed or plant. Technavio’s analysts forecast …
- 再生ガラスの世界市場：製品別（カレット、粉砕ガラス、ガラス粉末）、用途別（ボトル＆コンテナー、板ガラス、グラスファイバー、ハイウェイビーズ、その他）The global recycled glass market was valued at $3,529.2 million in 2017 and is projected to reach $5,544.9 million by 2025, growing at a CAGR of 5.7% from 2020 to 2025. Recycled Glass are glass obtained after processing of waste glass into usable products. Glass is 100% recyclable and is recycled from readily available domestic materials such as sand, limestone, soda ash, and cullet. . Out of all …
- フッ素エラストマーの世界市場：フルオロカーボンエラストマー、フルオロシリコーンエラストマー、パーフルオロエラストマーThis report on fluoroelastomers market covers latest market trends and forecasting reports for the global fluoroelastomers industry. Fluoroelastomers are polymeric resins in which some or all of the hydrogen atoms in the polymer chain have been replaced by fluorine. They offer a combination of good chemical resistance, excellent electrical insulation properties, and favorable mechanical properties …
- ハードウェアOTPトークン認証の世界市場2016-2020About Hardware OTP Authentication Hardware OTP authentication method enables organizations to secure their data with two-factor authentication. The hardware device that is being used is the first step of authentication followed by a security token that is issued to the user to verify the identity of the user. This two-factor authentication method enables secure business transactions and enhances u …
